TIBET PHARMACEUTICALS, INC. (a British Virgin Islands company) Minimum Offering: 2,500,000 Common Shares Maximum Offering: 3,000,000 Common Shares ($ per share) PLACEMENT AGREEMENTPlacement Agreement • October 18th, 2010 • Tibet Pharmaceuticals, Inc. • Pharmaceutical preparations • Virginia
The undersigned, Tibet Pharmaceuticals, Inc., a British Virgin Islands company (the “Company”), hereby confirms its agreement with you as follows:
TIBET PHARMACEUTICALS, INC. WARRANT AGREEMENTWarrant Agreement • October 18th, 2010 • Tibet Pharmaceuticals, Inc. • Pharmaceutical preparations • Virginia
Tibet Pharmaceuticals, Inc., a British Virgin Islands company (the “Company”), agrees to issue and sell to you a warrant (the “Warrant”) to purchase the number of common shares of the Company set forth herein, subject to the terms and conditions contained herein.
ESCROW AGREEMENTEscrow Agreement • October 18th, 2010 • Tibet Pharmaceuticals, Inc. • Pharmaceutical preparations • Virginia
This Escrow Agreement is made and entered into as of the th day of , 2010, by and among ANDERSON & STRUDWICK, INCORPORATED, a Virginia corporation (the “Placement Agent”), TIBET PHARMACEUTICALS, INC., a British Virgin Islands company (the “Company”) and SUNTRUST BANK (the “Escrow Agent”).
Lock-Up AgreementLock-Up Agreement • October 18th, 2010 • Tibet Pharmaceuticals, Inc. • Pharmaceutical preparations
The undersigned understands that Anderson & Strudwick, Incorporated (the “Placement Agent”), proposes to enter into a Placement Agreement with Tibet Pharmaceuticals, Inc. (the “Company”), providing for the public offering (the “Offering”), by the Placement Agent of a minimum of 2,500,000 common shares and a maximum of 3,000,000 common shares (the “Shares”).
LETTER OF ENGAGEMENT Tibet Pharmaceuticals, Inc. October 12, 2010Letter of Engagement • October 18th, 2010 • Tibet Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The following sets forth the agreement (this “Agreement”) for the engagement of Trilogy Capital Partners, Inc., (“Trilogy”) by Tibet Pharmaceuticals, Inc. (“Tibet” or the “Company”):
